Company intelligence / Profile preview

Astrea Fontaine

Fontaine-lès-Dijon, Côte-d'Or/Bourgogne-Franche-Comté, Franceastreapharma.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Astrea Fontaine is an active CDMO specializing in the manufacture of small molecule pharmaceuticals, with capabilities in both oral solid and aseptic dosage forms. The company operates from its site in Fontaine-lès-Dijon, France, which was acquired from Recipharm in early 2022. There is no evidence of proprietary clinical programs or direct drug development activities.

Modalities: Small moleculeOral solid dosageAseptic dosage
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Astrea Fontaine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astrea Fontaine.

Explore the full profile